Evaluation of Attitudes About Fertility

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Assess the attitudes and feelings of premenopausal Latin American women towards the risk of loss their fertility by adjuvant chemotherapy.
* Correlate the attitudes with other variables including age at diagnosis, already having children, number of children, level of instruction, marital status, frequency of menstrual cycle.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Eligibility criteria:

* Latin American women with evidence of cancer diagnosis at premenopausal status
* Over 18 years
* Agree to sign the informed consent
* No evidence of infertility.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

fertility chemotherapy breast cancer latin american women pre menopausal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women with breast cancer diagnosis in premenopausal
* over 18 years
* signed informed consent

Exclusion Criteria

* Evidence of infertility at diagnosis

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

HENRY L GOMEZ, DR

Role: PRINCIPAL_INVESTIGATOR

Grupo de Estudios Clínicos Oncológicos Peruano

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Instituto Nacional de Enfermedades Neoplasicas

Lima, Lima Province, Peru

Site Status

Oncosalud

Lima, Lima Province, Peru

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Peru

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

HENRY GOEMZ, DR

Role: primary

ALFREDO AGUILAR, MD